Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
CERETYPE NEUROMEDICINE IN has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $380,375 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in CAMBRIDGE, Massachusetts.
1 round · latest SBIR Phase I award (HHS), Apr 2025
Sign in to see 1 rounds.
Sign inNo investors recorded yet for CERETYPE NEUROMEDICINE IN.
Add an investorCERETYPE NEUROMEDICINE IN has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for CERETYPE NEUROMEDICINE IN.
Add diversity data